This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Beth Israel Deaconess Medical Center, Inc., Aalborg University. Active years: 2022-2026.
Company Filing History:
3 out of 536 
1 out of 43 Years Active: 2022-2026
Title: Riccardo Panella: Innovator in Metabolic Disorder Research
Introduction
Riccardo Panella is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of metabolic disorders, particularly through his innovative research on micro-RNA.
Latest Patents
Panella holds 3 patents that focus on groundbreaking methods for treating and preventing metabolic disorders. His latest patents include "Micro-RNA and obesity," which provides a method of treating or preventing metabolic disorders by administering agents that inhibit the activity of microRNAs that modulate metabolism. Another notable patent is "Inhibitors of micro-RNA 22," which offers compositions and methods that inhibit the activity of microRNAs, specifically miR-22.
Career Highlights
Throughout his career, Panella has worked with esteemed institutions such as Beth Israel Deaconess Medical Center and Aalborg University. His work has been instrumental in advancing the understanding of metabolic disorders and their treatment.
Collaborations
Panella has collaborated with notable colleagues, including Pier Paolo Pandolfi and Sakari Kauppinen, further enhancing the impact of his research in the scientific community.
Conclusion
Riccardo Panella's innovative work in the field of metabolic disorders showcases his dedication to advancing medical science. His contributions through patents and collaborations highlight his role as a key figure in this important area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile